Cite
HARVARD Citation
Nunes, J. et al. (2017). Use of a next generation maleimide in combination with THIOMAB™ antibody technology delivers a highly stable, potent and near homogeneous THIOMAB™ antibody-drug conjugate (TDC). RSC advances. 7 (40), pp. 24828-24832. [Online].